CTEV

Claritev Corporation

Healthcare · $371M market cap

Verdict

We can't put a fair value on CTEV right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

0 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth-49.3% a year✗
Sales growth-1.1% a year✗
Free cash flow growth-4.0% a year✗
Return on invested capital-7.8%✗

Follow CTEV

Track it on your watchlist and see the full analysis. Free.

Create a free account

Superinvestors

None of the investors we track holds CTEV right now. In Q2 2026, 1 sold out. Who we track

Moves in Q2 2026

Sold out: Daniel Loeb

About Claritev Corporation

Claritev Corporation, together with its affiliated companies, provides advanced data analytics and technology-enabled services focused on cost management, payment optimization, and revenue assurance for the healthcare sector across the United States. The company offers a suite of services designed to reduce medical expenses. This includes analytics-driven solutions that utilize sophisticated algorithms and data…

Medical - Healthcare Information Services

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works